eNauka - pregled

Pregled prema Autor Tan, Antoinette R

Prikaz rezultata 1 do 4 od 4
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2021Trial in progress: A phase 3, randomized, double-blind trial of trilaciclib versus placebo in patients receiving first- or second-line gemcitabine and carboplatin for locally advanced unresectable or metastatic triple-negative breast cancer (PRESERVE 2).Goel, Shom; O'Shaughnessy, Joyce; Tan, Antoinette R; Milev-Krastev, Boris; Rugo, Hope S; Aftimos, Philippe Georges; Yardley, Denise A; Andric, Zoran G  ; Wolfgang, Curt Douglas; Sorrentino, Jessica;
Tao, Wenli; Beelen, Andrew Paul; Malik, Rajesh K; Jain, Sarika;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2019Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trialTan, Antoinette R; ...; Popovic, Lazar S  ; ...; Milenkovic, Dusan M; ...; (broj, koautora 17)Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2022Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II StudyTan, Antoinette R; Wright, Gail; Thummala, Anu; Danso, Michael; Popovic, Lazar S  ; Pluard, Timothy; ...et al.; Milenkovic, Dusan M; (broj, koautora 17)Naučni članak
21a+M21a+
2022Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2Goel, Shom; Tan, Antoinette R; Rugo, Hope S; Aftimos, Philippe; Andric, Zoran G  ; Beelen, Andrew Paul; Zhang, Jingshan; Yi, John S; Malik, Rajesh K; O'Shaughnessy, JoyceArticle
22M22